Skip to main content

Evidence-Based Supplement Research

Evidence-Based Supplement Research

Streptococcus salivarius K12 and Reduced Otopathogen Prevalence

Time to effect

Median: 4.3 weeks · IQR 4.3 weeks–4.3 weeks · Range 4.3 weeks–4.3 weeks — Reported in 1 of 1 study

1 of 1 paper

Impact of Streptococcus salivarius K12 on Nasopharyngeal and Saliva Microbiome: A Randomized Controlled Trial.
- 2020-12-08
- RCT · n = 121
- The Pediatric infectious disease journal 40(5)
- - Suvi Sarlin
  - Mysore V Tejesvi
  - Jenni Turunen
  - Petri Vänni
  - Tytti Pokka
  - Marjo Renko
  - Terhi Tapiainen
- PubMed: 33298762
- DOI: 10.1097/inf.0000000000003016
10 Insights on
- Reduced Otopathogen Prevalence
- High evidence
- Large Human Trial
- Children
The proportion of children with any otopathogen did not differ between the groups.
Effect
Neutral
Effect size
Small
Significant
No
Dose
not stated